Clock genes and cancer

Integrative Cancer Therapies

Volumn 8, Issue 4, 2009, Pages 303-308

  Wood, Patricia A ^a   Yang, Xiaoming ^a   Hrushesky, William J M ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

catenin; Circadian; Colon cancer; Neoplasm; Period genes; Polyps

Indexed keywords

APC PROTEIN; BETA CATENIN; CELL CYCLE PROTEIN; CRYPTOCHROME 1; CRYPTOCHROME 2; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1;

ANIMAL MODEL; CELL CYCLE PROGRESSION; CIRCADIAN RHYTHM; COLON CANCER; COLON POLYP; DNA POLYMORPHISM; DNA REPAIR; GENE MUTATION; LIGHT EXPOSURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CIRCADIAN RHYTHM; COLONIC NEOPLASMS; COLONIC POLYPS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, MUTANT STRAINS; MUTATION; NEOPLASMS; PERIOD CIRCADIAN PROTEINS;

EID: 77949390693     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735409355292     Document Type: Review

References (43)

1. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet. 2006;15(2):R271-R277.
2. Miller BH, McDearmon EL, Panda S, et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A. 2007;104: 3342-3347.
3. Wood PA, Du-Quiton J, You S, Hrushesky WJ. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006;5:2023-2033.
4. Dagenais-Bellefeuille S, Bertomeu T, Morse D. S-phase and M-phase timing are under independent circadian control in the dinoflagellate Lingulodinium. J Biol Rhythms. 2008;23: 400-408.
5. Dekens MP, Santoriello C, Vallone D, Grassi G, Whitmore D, Foulkes NS. Light regulates the cell cycle in zebrafish. Curr Biol. 2003;13:2051-2057.
6. Gorbacheva VY, Kondratov RV, Zhang R, et al. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci U S A. 2005;102: 3407-3412.
7. Hrushesky WJ. Circadian timing of cancer chemotherapy. Science. 1985;228:73-75.
8. Hrushesky WJ, Bjarnason GA. Circadian cancer therapy. J Clin Oncol. 1993;11:1403-1417.
9. Hrushesky WJ, Roemeling RV, Wood PA, Langevin TR, Lange P, Fraley E. High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer. Cancer Treat Rep. 1987;71:915-919.
10. Kang TH, Reardon JT, Kemp M, Sancar A. Circadian oscillation of nucleotide excision repair in mammalian brain. Proc Natl Acad Sci U S A. 2009;106:2864-2867.
11. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302:255-259.
12. Sothern RB, Levi F, Haus E, Halberg F, Hrushesky WJ. Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst. 1989;81:135-145.
13. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111:41-50.
14. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314:268-274.
15. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood. 2005;106:2827-2836.
16. Krugluger W, Brandstaetter A, Kallay E, et al. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res. 2007;67: 7917-7922.
17. Mostafaie N, Kallay E, Sauerzapf E, et al. Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. Mol Carcinog. 2009;48: 642-647.
18. Yang MY, Chang JG, Lin PM, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 2006;97:1298-1307.
19. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006;22:375-382.
20. Hua H, Wang Y, Wan C, et al. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther. 2007;14:815-818.
21. Hua H, Wang Y, Wan C, et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 2006; 97:589-596.
22. Marino JL, Holt VL, Chen C, Davis S. Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology. 2008;19:477-484.
23. Zhu Y, Stevens RG, Leaderer D, et al. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat. 2008;107:421-425.
24. Zhu Y, Leaderer D, Guss C, et al. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer. 2007;120:432-435.
25. Miki I, Tamura T, Nakamura T, et al. Circadian variability of pharmacokinetics of 5-fluorouracil and CLOCK T3111C genetic polymorphism in patients with esophageal carcinoma. Ther Drug Monit. 2005;27:369-374.
26. Wood PA, Yang X, Taber A, et al. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res. 2008;6: 1786-1793.
27. Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. Does "clock" matter in prostate cancer? Cancer Epidemiol Biomarkers Prev. 2006;15:3-5.
28. Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period 3 structural variation: a circadian biomarker associated with breast. Cancer Epidemiol Biomarkers Prev. 2005;14: 268-270.
29. Gauger MA, Sancar A. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 2005;65: 6828-6834.
30. Ozturk N, Lee JH, Gaddameedhi S, et al., (2009): Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci USA.; 106(8):2841-2846.
31. Hoffman AE, Zheng T, Stevens RG, et al. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene Cryptochrome 2. Cancer Res. 2009;69:3605-3613.
32. Chu LW, Zhu Y, Yu K, et al. Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis. 2008;11:342-348.
33. Antoch MP, Gorbacheva VY, Vykhovanets O, et al. Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle. 2008;7:1197-1204.
34. Reick M, Garcia JA, Dudley C, McKnight SL. NPAS2: an analog of clock operative in the mammalian forebrain. Science. 2001;293:506-509.
35. Kondratov RV, Chernov MV, Kondratova AA, Gorbacheva VY, Gudkov AV, Antoch MP. BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev. 2003;17:1921-1932.
36. Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJ. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 2009;117:423-431.
37. You S, Li W, Kobayashi M, Xiong Y, Hrushesky W, Wood P. Creation of a stable mammary tumor cell line that maintains fertility cycle tumor biology of the parent tumor. In Vitro Cell Dev Biol Anim. 2004;40:187-195.
38. Yang X, Wood PA, Ansell CM, et al., (2009): The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int ; 26(7): 1340-1354.
39. Noubissi FK, Elcheva I, Bhatia N, et al. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature. 2006;441:898-901.
40. Shirogane T, Jin J, Ang XL, Harper JW. SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1- dependent degradation of the mammalian period-1 (Per1) protein. J Biol Chem. 2005;280:26863-26872.
41. Eide EJ, Woolf MF, Kang H, et al. Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol. 2005;25:2795-2807.
42. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 2007;56:417-425.
43. Yang X, Wood PA, Ansell CM, et al. Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem. 2009;145:289-297.